Kostas Kafetzis

Kostas Kafetzis, PhD, is an active researcher specializing in nanomedicine and drug delivery systems within Pharmacology, Toxicology and Pharmaceutical Science. His work focuses on developing innovative nanoparticle-based therapies for various medical conditions, particularly in ophthalmology and neurological disorders.

Dr. Kafetzis' research interests center around nanotechnology applications in medicine, with particular expertise in lipid nanoparticles, siRNA delivery systems, and exosome therapies. His work bridges the gap between pharmaceutical science and clinical applications, with several publications examining the translation of nanomedicine from bench to bedside.

His recent publications demonstrate a strong trend toward developing targeted delivery systems for eye conditions, particularly glaucoma and fibrosis prevention, as well as exploring novel approaches for treating neurological disorders through blood-brain barrier modulation. The research shows increasing focus on practical implementation challenges such as nanoparticle stability, storage conditions, and safety profiles.

Dr. Kafetzis has established significant collaborations with researchers across multiple institutions, contributing to impactful work in nanomedicine that has garnered substantial attention in academic circles and generated numerous citations across his publications.